Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
Status:
Recruiting
Trial end date:
2025-08-31
Target enrollment:
Participant gender:
Summary
Long-term beta-blocker therapy has not been investigated in contemporary randomized clinical
trials in patients with myocardial infarction and normal heart function. The aim of this
study is to determine whether long-term treatment with oral beta-blockade in patients with
myocardial infarction and preserved left ventricular systolic ejection fraction reduces the
composite of death of any cause or new myocardial infarction..